Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure.
OBJECTIVE
To investigate the relationship between the period of mechanical ventilation before extracorporeal life support and survival in patients with respiratory failure.


METHODS
Retrospective review.


METHODS
Surgical intensive care unit at a university medical center.


METHODS
Thirty-six consecutive adult patients with severe respiratory failure managed with extracorporeal life support.


METHODS
Extracorporeal life support was utilized in 36 acute respiratory failure adult patients with a variety of diagnoses and an estimated mortality rate of > 90%. Management protocols were followed before and during extracorporeal life support. The 36 patients were physiologically similar before extracorporeal life support was initiated: shunt of 48 +/- 17%; F10(2) of 1.0 +/- 0.1; peak inspiratory pressure of 56 +/- 16 cm H2O; positive end-expiratory pressure of 14 +/- 6 cm H2O; and respiratory rate of 23 +/- 10 breaths/ min. Ventilation was utilized for 1 to 17 days before extracorporeal life support. Typical lung rest settings during extracorporeal life support were F10(2) of 0.40, peak inspiratory pressure of 30 cm H2O, positive end-expiratory pressure of 10 cm H2O, and respiratory rate of 6 breaths/min. Death was almost always secondary to end-stage pulmonary failure.


RESULTS
Survival (hospital discharge) in these 36 patients was inversely associated with the number of days of preextracorporeal life support ventilation, with a 50% mortality rate predicted by logistic regression after 5 days of mechanical ventilation. The overall survival rate was 18 (50.0%) of 36 patients.


CONCLUSIONS
In severe acute respiratory failure treated with lung rest and extracorporeal life support, a predicted 50% mortality rate was associated with 5 days of preextracorporeal life support mechanical ventilation.
Pranikoff
T
T
Department of Surgery, University of Michigan School of Medicine, Ann Arbor, USA.
Hirschl
R B
RB
Steimle
C N
CN
Anderson
H L
HL
Bartlett
R H
RH
D000328:Adult; D000818:Animals; D003422:Critical Care; D015199:Extracorporeal Membrane Oxygenation / Q000401:mortality; D006801:Humans; D011175:Positive-Pressure Respiration; D012121:Respiration, Artificial / Q000009:adverse effects / Q000401:mortality*; D012131:Respiratory Insufficiency / Q000209:etiology / Q000401:mortality* / Q000628:therapy*; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors